Altris - FDA, CE certified AI-powered OCT analysis

Altris AI launched Optic Disc Analysis for Glaucoma module. youtube.com/watch?v=DN6gH8…

Detection of Diabetic Retinopathy: The AI Advantage healthcarebusinessclub.com/articles/healt… via @Healthcare Business Club

If you are at @aao_ophth event these days, visit booth 4058 to learn about AI-powered OCT analysis

Meet our expert team at @aao_ophth on 19-21 October in Chicago.

Visit @AltrisAi Booth 4058 at @aao_ophth event in Chicago on 19-21 October. See how AI for OCT analysis actually works!

Visit Booth A7100 at @ESCRSofficial to learn about AI for OCT and @Altris_AI

@Altris_AI is among 3 AI Technologies I Use in My Optometry Practice to Improve Care reviewob.com/3-ai-technolog…

Altris AI, a leading AI software provider for OCT scan analysis, announces the appointment of Grant Schmid as the Vice President of Business Development. Mr. Schmid is a proven leader in the eye care industry and has solid experience that will help him lead corporate sales.

#aiinoptometry is getting more and more widespread and progressive ODs are already using it

@Neal_Suchak @CollegeOptomUK Please consider AI for OCT analysis as the new tech to unlock

The next government has a real opportunity to turn the dial on eye care. 3x @CollegeOptomUK priorities: 1. Optometrists to provide more care closer to home. 2. Better-connected NHS & unlock new tech. 3. Support the optom workforce to develop skills. college-optometrists.org/viewpoint/mani…

Early glaucoma risk analysis is what we are proud of at @Altris_AI as it can help millions of people to save vision. #aioptometry #aiglaucoma #aiophthalmology

Seamless referral for UK optometrists is possible. @PocketEye & @Altris_AI partner to offer more effective referrals. Check: altris.ai/optometry-refe…

@PocketEye & @AltrisAi partner to support UK optometrists with professional clinical advice, guidance, and AI-powered OCT analysis. Learn more: altris.ai/optometry-refe…

AI for biomarker detection on medical images is the most feasible and accessible use case of AI in pharma today. #aiinpharma #aidrugdevelopment #aiclinicalrial

40% of patients don't know what OCT is. Here is where @Altris_AI color coding becomes extremely useful. altris.ai/article/ai-ass…

If you want to experience AI for OCT, get registered in a demo account: demo.altris.ai

AI for Glaucoma Early Risk Assessment on OCT youtu.be/JjY0wSs-aLk?si… via @YouTube

About 80% (8 out of 10) of people who have AMD have the dry form. Dry AMD is when parts of the macula get thinner with age and tiny clumps of protein called drusen grow. People with dry AMD may have drusen, pigment abnormalities, or geographic atrophy.

@Altris_AI team along with @MZnamenska gathered 250 ophthalmologists and optometrists for the Ophthalmic Christmas!

EyecareForum managed to gather curious eye care specialists who were ready to learn about Artificial Intelligence for OCT analysis from our Head of Clinical Sales Mark Braddon.